Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART) | MicrobiomeTrials← Back to trialsNCT06280820
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2026-07-30Est. Completion: 2028-04-30
Enrollment target: 2,000 participants Locations- INOVA Fairfax Hospital, Falls Church, Virginia, United States
Other microbiome trials you might be interested in
Heart Failure NYHA Class III
This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Co…
Aalst, BelgiumEst. completion Oct 30, 2021
Sustained Monomorphic VT (MMVT)Recurrent Ventricular Tachycardia
This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guide…
Phoenix, United StatesEst. completion Apr 30, 2028
Acute Respiratory Distress SyndromePneumonia in ChildrenRespiratory Failure (Pediatric Patients)Congenital Heart Disease in Children
This prospective, randomized controlled trial aims to evaluate whether an AI-driven decision support system can improve …
Multiple LocationsEst. completion Dec 31, 2027